ONE Bio Corp. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

ONE Bio Corp. Fundamental Company Report provides a complete overview of the company’s affairs. All available data is presented in a comprehensive and easily accessed format. The report includes financial and SWOT information, industry analysis, opinions, estimates, plus annual and quarterly forecasts made by stock market experts. The report also enables direct comparison to be made between ONE Bio Corp. and its competitors. This provides our Clients with a clear understanding of ONE Bio Corp. position in the Chemical Industry.

Scope

• The report contains the company’s profile and data about the owners, senior executives, locations, subsidiaries, markets, products, and company history.
• The SWOT-analysis provides information about the company’s strengths, weaknesses, opportunities, and possible threats against it.
• The report outlines the main financial ratios pertaining to profitability, margin analysis, asset turnover, credit ratios, and company’s long-term solvency.
• It also shows the company’s income statement and ratio trend-charts, with balance sheets and cash flows presented on an annual and quarterly basis.
• Company’s financial ratios are directly compared with those of its competitors through industry averages.
• The report provides relevant news, an analysis of PR-activity, and stock price movements.
• The latter are correlated with pertinent news and press releases, and annual and quarterly forecasts are given by a variety of experts and market research firms.

The benefits of buying the Report are as follows:

• Readers will gain an unrivalled in-depth knowledge about the company.
• The report will help the management of your business environment. This will be achieved through the report’s unique analysis of both the market and company’s competitors, and by providing detailed information about the internal and external factors that affect the relevant industry.
• Your company’s business and sales activities will be boosted by gaining an insight into your competitors’ businesses.
• The report will help you to find prospective partners and suppliers.
• The annual profitability data provided in the report will assist and strengthen your company’s decision-making processes.

About ONE Bio Corp.

ONE Bio, Corp., a bio-engineering company, through its subsidiaries, produces raw chemicals and herbal extracts, natural supplements, and organic products utilizing green process manufacturing in the Asia Pacific region. The company’s primary products include Solanesol, CoQ10, Resveratrol and 5-HTP, organic fertilizers, and organic bamboo health food and beverages.

Business Units

The company’s operations are divided into two principal business units that focus on producing chemical and herbal extracts (CHE business unit) and organic products utilizing green processes (OP business unit).

Green Planet and its CHE operating division

The company’s CHE business unit operates under the umbrella of its subsidiary Green Planet Bioengineering, Co., Ltd. (GP) which contractually controls and operates Sanming Huajian Bio-Engineering Co., Ltd. (Sanming). Sanming is the principle operating enterprise of this business unit and is located in the Peoples’ Republic of China (PRC). Sanming is a research and development company, focuses on human health through the development, manufacture, and commercialization of bio-ecological products and over-the-counter products utilizing extractions from tobacco leaves.

The company’s CHE unit produces chemical and herbal extracts for use in a range of health and wellness products. Utilizing green technology and proprietary processes, this unit extracts health supplements, fertilizers, and pesticides from waste tobacco. Its chemical extraction processes from tobacco leaves and delivers Solanesol (98%) which would be further extracted into CoenzymeQ10 (CoQ10). The discarded tobacco leaves are further extracted to produce organic fertilizers both powdered and particulate and thereby substantially eliminates waste in the process. Its CHE unit also extracts from various plants Resveratrol and 5-HTP, which are main components in various consumer health and wellness products. The company's distributors are focused on the bio-health industry and raw chemical intermediates industry.

UGTI and its OP operating division

The company’s OP business unit operates under the umbrella of its subsidiary united Green Technology Inc. (UGTI), which controls and operates Jianou Lujian Foodstuff Co. (JLF). JLF is the principle operating enterprise of this business unit and is located in the PRC. JLF is a green-technology enterprise that produces organic products and fertilizers based on bamboo. JLF concentrates on processing bamboo shoots and bamboos which it sells domestically in China and exports to other countries.

The company’s OP unit manufactures various consumer and commercial-use health and energy drinks, organic food products, and fertilizers primarily based on bamboo. Organic food products based on bamboo are low in saturated fat, cholesterol and sodium yet high in dietary fiber, vitamin C, potassium, zinc, and numerous other nutrients, making bamboo shoots used for weight loss and maintaining a healthy lifestyle. Also, the Moso bamboo leaf extract, which contains soluble and insoluble fiber and antioxidants, is used to make a caffeine-free energy drink or is infused into white rice creating green bamboo rice with health benefits. The company’s OP unit also uses bamboo skins to produce organic fertilizers, thereby substantially eliminating waste in the process.

The boiled bamboo shoots and mixed vegetables products sold domestically and exported to other countries, such as Japan, southeast Asia, Europe, and North America. The company distributes its OP products directly to supermarket chains (such as Kobe Bussan in Japan), hotels, hospitals, and restaurants.

Acquisitions

In 2009, the company acquired 99.75% interest in Trade Finance Solutions (TFS), which provides balance sheet financing solutions for domestic and international credit-worthy customers including accounts receivable, purchase order financing, fulfillment services, and factoring or invoice discounting.

History

The company was founded in 2002. It was formerly known as ONE Holdings, Corp. and changed its name to ONE Bio Corp. in 2009.

Contents

RESEARCH METHODOLOGY

DISCLAIMER

1. ONE BIO CORP. COMPANY PROFILE

1.1. Key facts
1.2. Financial Performance
1.3. Key Executives
1.4. Ownership and Major Holders
1.5. Company History

2. ONE BIO CORP. BUSINESS OVERVIEW

2.1. Business Description
2.2. Major Products and Services
2.3. Markets and Sales Activities
2.4. Locations, Subsidiaries, Operating Units

3. ONE BIO CORP. SWOT ANALYSIS

3.1. Overview
3.2. Strengths
3.3. Weaknesses
3.4. Opportunities
3.5. Threats

4. ONE BIO CORP. FINANCIAL ANALYSIS

4.1. Financial Statements
  4.1.1. Income Statement
  4.1.2. Balance Sheet
  4.1.3. Cash Flow
4.2. Financial Ratios
  4.2.1. Profitability
  4.2.2. Margin Analysis
  4.2.3. Asset Turnover
  4.2.4. Credit Ratios
  4.2.5. Long-Term Solvency
  4.2.6. Growth Over Prior Year
  4.2.7. Financial Ratios Charts
4.3. Stock Market Snapshot

5. ONE BIO CORP. COMPETITORS AND INDUSTRY ANALYSIS

5.1. ONE Bio Corp. Direct Competitors
5.2. Comparison of ONE Bio Corp. and Direct Competitors Financial Ratios
5.3. Comparison of ONE Bio Corp. and Direct Competitors Stock Charts
5.4. ONE Bio Corp. Industry Analysis
  5.4.1. Chemicals Industry Snapshot
  5.4.2. ONE Bio Corp. Industry Position Analysis

6. ONE BIO CORP. NEWS & EVENTS

6.1. News & PR Activity Analysis
6.2. IR Corporate News
6.3. Marketing News
6.4. Corporate Events

7. ONE BIO CORP. EXPERTS REVIEW

7.1. Experts Opinion
7.2. Experts Estimates

APPENDIX 1: RATIO DEFINITIONS

LIST OF TABLES

Table 1. ONE Bio Corp. Key Facts
Table 2. ONE Bio Corp. Profitability
Table 3. ONE Bio Corp. Management Effectiveness
Table 4. ONE Bio Corp. Income Statement Key Figures
Table 5. ONE Bio Corp. Balance Sheet Key Figures
Table 6. ONE Bio Corp. Cash Flow Statement Key Figures
Table 7. Financial Performance Abbreviation Guide
Table 8. ONE Bio Corp. Key Executives
Table 9. ONE Bio Corp. Key Executives Biographies *
Table 10. ONE Bio Corp. Key Executives Compensations *
Table 11. ONE Bio Corp. Key Executives Stock Options *
Table 12. ONE Bio Corp. Major Shareholders
Table 13. ONE Bio Corp. History
Table 14. ONE Bio Corp. Products
Table 15. ONE Bio Corp. Revenues by Product
Table 16. ONE Bio Corp. Revenues by Region
Table 17. ONE Bio Corp. Offices and Representations
Table 18. ONE Bio Corp. SWOT Analysis
Table 19. ONE Bio Corp. Income Statement 2008-2011 Including 4-years Trends
Table 20. ONE Bio Corp. Income Statement Latest 4 Quarters Including Trends
Table 21. ONE Bio Corp. Balance Sheet 2008-2011 Including Trends
Table 22. ONE Bio Corp. Balance Sheet Latest 4 Quarters Including Trends
Table 23. ONE Bio Corp. Cash Flow 2008-2011 Including Trends
Table 24. ONE Bio Corp. Cash Flow Latest 4 Quarters Including Trends
Table 25. ONE Bio Corp. Profitability Ratios
Table 26. ONE Bio Corp. Margin Analysis Ratios
Table 27. ONE Bio Corp. Asset Turnover Ratios
Table 28. ONE Bio Corp. Credit Ratios
Table 29. ONE Bio Corp. Long-Term Solvency Ratios
Table 30. ONE Bio Corp. Financial Ratios Growth Over Prior Year
Table 31. ONE Bio Corp. Capital Market Snapshot
Table 32. ONE Bio Corp. Direct Competitors Key Facts
Table 33. ONE Bio Corp. Direct Competitors Profitability Ratios
Table 34. ONE Bio Corp. Direct Competitors Margin Analysis Ratios
Table 35. ONE Bio Corp. Direct Competitors Asset Turnover Ratios
Table 36. ONE Bio Corp. Direct Competitors Credit Ratios
Table 37. ONE Bio Corp. Direct Competitors Long-Term Solvency Ratios
Table 38. Chemicals Industry Statistics
Table 39. ONE Bio Corp. Industry Position
Table 40. ONE Bio Corp. vs. Industry Income Statement Analysis
Table 41. ONE Bio Corp. vs. Industry Balance Sheet Analysis
Table 42. ONE Bio Corp. vs. Industry Cash Flow Analysis
Table 43. ONE Bio Corp. vs. Industry Ratios Comparison
Table 44. ONE Bio Corp. Consensus Recommendations*
Table 45. ONE Bio Corp. Analyst Recommendation Summary*
Table 46. ONE Bio Corp. Price Target Summary*
Table 47. ONE Bio Corp. Experts Recommendation Trends*
Table 48. ONE Bio Corp. Revenue Estimates Analysis*
Table 49. ONE Bio Corp. Earnings Estimates Analysis*
Table 50. ONE Bio Corp. Historical Surprises*
Table 51. ONE Bio Corp. Revenue Estimates Trend*
Table 52. ONE Bio Corp. Earnings Estimates Trend*
Table 53. ONE Bio Corp. Revenue Revisions*
Table 54. ONE Bio Corp. Earnings Revisions*

LIST OF FIGURES

Figure 1. ONE Bio Corp. Annual Revenues in Comparison with Cost of Goods Sold and Gross Profit
Figure 2. ONE Bio Corp. Profit Margin Chart
Figure 3. ONE Bio Corp. Operating Margin Chart
Figure 4. ONE Bio Corp. Return on Equity (ROE) Chart
Figure 5. ONE Bio Corp. Return on Assets (ROA) Chart
Figure 6. ONE Bio Corp. Debt to Equity Chart
Figure 7. ONE Bio Corp. Current Ratio Chart
Figure 8. ONE Bio Corp. 1-year Stock Charts
Figure 9. ONE Bio Corp. 5-year Stock Charts
Figure 10. ONE Bio Corp. vs. Main Indexes 1-year Stock Chart
Figure 11. ONE Bio Corp. vs. Direct Competitors 1-year Stock Charts
Figure 12. ONE Bio Corp. Article Density Chart

* – Data availability depends on company’s security policy.
The complete financial data is available for public traded companies.

The above Company Fundamental Report is a half-ready report.
It means that we have all necessary data in our database to prepare the report but need 2-3 days to complete it. During this time we are also updating the report with respect to the current moment. So, you can get up-to-date version for the same price.